MS
Matthew Sykes Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
45.5%
Neutral
36.4%
Negative
18.2%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $5 |
49%
downside
| 1 | – |
–
| 14 May ‘25 11 months ago |
|
|
|
Sell
Maintained
| $3 |
32%
downside
| 1 | -39% |
0
%
| 12 May ‘25 11 months ago |
|
|
|
Sell
Maintained
| $6.50 |
71%
downside
| 1 | -93% |
0
%
| 12 May ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $45 |
23%
upside
| 1 | – |
–
| 8 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $8 |
67%
upside
| 2 | -23% |
0
%
| 7 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $48 |
21%
downside
| 1 | +26% |
0
%
| 6 May ‘25 11 months ago |
|
|
|
Buy
Upgraded
| $17 |
9%
upside
| 1 | +11% |
0
%
| 5 May ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $160 |
57%
upside
| 2 | -17% |
–
| 2 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $10 |
21%
upside
| 2 | -3% |
0
%
| 30 Apr ‘25 1 year ago |
|
|
|
Buy
Maintained
| $125 |
44%
upside
| 1 | -9.4% |
0
%
| 29 Apr ‘25 1 year ago |
|
|
|
Neutral
Downgraded
| $14 |
77%
upside
| 1 | – |
–
| 29 Apr ‘25 1 year ago |
|